The government ordered 14 unapproved narcotic painkillers off the market Tuesday, prescription versions of potent morphine, hydromorphone and oxycodone.
The Food and Drug Administration told nine manufacturers to quit distributing the drugs within 90 days - but insisted there are plenty of legal versions of the painkillers being sold for patients who need relief.
"There will be no shortage for consumers," said Deborah Autor, director of FDA's drug compliance office.
The move is part of the FDA's years-long attempt to weed out thousands of prescription drugs that sell despite never being formally approved by the health regulatory agency. Many entered the market decades ago, before federal law required such approval.
The FDA estimates that unapproved drugs account for 2 percent of all prescriptions filled.
Tuesday, the FDA targeted unapproved versions of high-concentrate liquid morphine sulfate and unapproved immediate-release tablets containing morphine sulfate, hydromorphone and oxycodone. Most are generic.
To help consumers tell if they have an approved or unapproved version, the FDA posted both lists on its Web site.
Manufacturers receiving warning letters Tuesday are:
Boehringer Ingelheim Roxane Inc. of Columbus, Ohio; Cody Laboratories Inc. of Cody, Wyo.; Glenmark Pharmaceuticals Inc. of Mahwah, N.J.; Lannett Co. (LCI) Inc. of Philadelphia; Lehigh Valley Technologies Inc. of Allentown, Pa.; Mallinckrodt Inc. Pharmaceuticals Group of St. Louis; Physicians Total Care inc. of Tulsa; Roxane Laboratories Inc. of Columbus, Ohio; and Xanodyne Pharmaceutical Inc. of Newport, Ky.
The largest, Boehringer, didn't immediately return a call seeking comment.
Even FDA-approved versions of these painkillers pose a risk of serious side effects, but the unapproved products add an extra problem: Regulators haven't checked that those versions work as well and are as pure as their approved competitors.
Companies that don't heed the FDA's deadline could face big penalties: The government once seized $24 million worth of unapproved drugs from a company that ignored a stop-selling order, Autor noted.
If you're a smoothie lover, take note. Eight spots in your kitchen -- including your blender -- may be alive with foodborne pathogens potent enough to sicken you and your family, a new study finds.
It will be weeks, at least, before Celeste Corcoran is anywhere near ready to think about artificial limbs. The 47-year-old Lowell, Mass.
Ethan Remmel was only 41 when he died on June 13, 2011, barely a year after being diagnosed with terminal colon cancer that quickly spread to his bone. The Bellingham, Wash.
New Jersey Gov. Chris Christie revealed that he's had gastric-band weight-loss surgery, which experts say has the least amount of short-term risk but also yields the least amount of weight loss.
A new line of caffeinated chewing gum is causing jitters among health advocates and prompting federal officials to take a new look at the proliferation of jolt-infused foods, including those marketed to children and teens.
Stress, the slowing of metabolism of middle age, and hormone changes after having a baby are three main reasons why many people see the numbers on the scale going up. Dr. Mehmet Oz shares tips on how to shed those final 10 pounds.
Forget the old high school clichés about athletes not doing as well academically as less sporty kids -- a new study shows that children who exercise more do better in math, reading tests.
The procrastinators, the super-busy, and the easily bored in pursuit of a manageable fitness routine may find what they seek in the 10-minute workout.
Exercise not only improves mood, it may help people maintain reduced anxiety in the face of stressful or emotional events, a new study says.